Search

Author/Creator Fellmann, Marc

1. Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis. (May 2021)

Authors:
Rubin, David T.; Reinisch, Walter; Greuter, Thomas; Kotze, Paulo G.; Pinheiro, Marcia; Mundayat, Rajiv; Maller, Eric; Fellmann, Marc; Lawendy, Nervin; Modesto, Irene; Vavricka, Stephan R.; Lichtenstein, Gary R.
Journal:
Therapeutic advances in gastroenterology
Issue:
Volume 14(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study. (May 2022)

Authors:
Vavricka, Stephan R.; Greuter, Thomas; Cohen, Benjamin L.; Reinisch, Walter; Steinwurz, Flavio; Fellmann, Marc; Guo, Xiang; Lawendy, Nervin; Paulissen, Jerome; Peyrin-Biroulet, Laurent
Journal:
Therapeutic advances in gastroenterology
Issue:
Volume 15(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. S1023 Assessment of Health-Related Quality of Life and Patient-Reported Outcomes With Tofacitinib Treatment Stratified by Age in Patients From the OCTAVE Ulcerative Colitis Clinical Program. (October 2022)

Authors:
Biedermann, Luc; Hart, Ailsa; Panés, Julian; Rubin, David T.; Fellmann, Marc; Gardiner, Sean; Paulissen, Jerome; Almadi, Majid A.
Other Names:
Dubinsky Marla C. presenter.
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10S
Page Start:
e741
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗